Veblocema 120 mg, solution injectable en stylo prérempli

7680678880017 CH-67888 Lösung
Veblocema 120 mg, solution injectable en stylo prérempli
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/08/2025
Patient information leaflet
Français
15/08/2025
Patient information leaflet
Italien
15/08/2025
Summary of Product Characteristics
Allemand
15/08/2025
Summary of Product Characteristics
Français
15/08/2025
Summary of Product Characteristics
Italien
15/08/2025

Detailed composition

Substance Quantity Type Category
infliximabum
120.0 MG Substance Wirkstoff (Principe actif)
acidum aceticum
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
sorbitolum
45.0 MG Substance HBESI
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.16 MG Substance HBESI

Reimbursement information

Public price
CHF 592.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2022

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
67888
Drug name
Veblocema, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
L04AB02
Authorization status
Z
Dispensing category
A
First authorization
29/06/2021
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
VEBLOCEMA sol inj 120 mg/ml stylo pré
Description (DE)
VEBLOCEMA Inj Lös 120 mg/ml Fertpen
Market launch
29/06/2021
Narcotic (BTM)
No

Other package sizes (2)

None
2 INJ
GTIN: None
Not in V1
None
4 INJ
GTIN: None
Not in V1
Buy us a coffee Explore the data